Acelyrin Current Cash

The latest current cash for SLRN is $58M as of March 2025. That compares with $260M in the prior-year period — down 78.0% year over year. Investors often review this figure alongside Acelyrin's historical trend and sector peers before judging valuation or financial health.

Over the past year, SLRN's current cash moved from $260M to $58M — a 78.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Acelyrin's operating scale or balance-sheet position.

A current cash figure of $58M for SLRN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SLRN's current cash ($58M), review year-over-year change from $260M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.